Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Transplantation|June 4, 2002
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacyFu L Luan, Minoru Hojo, Mary Maluccio, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 25, 2005
Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccinationShigeki Nabeshima, Masayuki Murata, Kouzaburo Yamaji, et al.International Immunopharmacology|February 21, 2004
Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicineShigeki Nabeshima, Masayuki Murata, Maki Hamada, et al.Journal of Medical Virology|June 2, 2004
Downregulation of CXCR5 in CD27- B cells of HIV-1 infected patientsYong Chong, Shigeki Nabeshima, Norihiro Furusyo, et al.Cytokine|March 9, 2006
A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell linesMasayuki Murata, Shigeki Nabeshima, Kensuke Kikuchi, et al.International Immunology|February 23, 2005
CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbancesYong Chong, Hideyuki Ikematsu, Kouzaburo Yamaji, et al.Cancer Immunology, Immunotherapy : CII|July 26, 2005
Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatmentKouzaburo Yamaji, Shigeki Nabeshima, Masayuki Murata, et al.Molecular Immunology|September 6, 2002
Two V(H)5 family genes expressed by human peripheral B cells display differential mutational frequencies in the V(H) regionYong Chong, Hideyuki Ikematsu, Masayuki Murata, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 8, 2006
[Varicella-zoster virus symptoms and polyneuropathy in a patient with human immunodeficiency virus infection not improved until highly active anti-retroviral therapy added to acyclovir therapy]Hiroaki Takeoka, Yong Chong, Masayuki Murata, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 25, 2008
The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosaShin-ichi Harashima, Hiroko Kondo, Atsuko Nabeshima, et al.Pageof 2